Our previous demonstration that CD147 expression in epithelial mammary tumor cells is increased by the EGF/EGFR system [69] suggests that the activation of EGFR signaling may account, at least partially, to the increased expression of CD147 observed in most carcinomas and to the therapeutic potential of EGFR inhibitors. Here, BSG is linked to carcinoma.